Cargando…
Laboratory markers of severity across three COVID-19 outbreaks in Australia: has Omicron and vaccinations changed disease presentation?
COVID-19 has rapidly evolved since it was first discovered in December 2019. We aimed to retrospectively review our experience with COVID-19 infection across 2020–2022, focusing on differences in laboratory markers at presentation. Consecutive adult patients admitted to hospital with confirmed COVID...
Autores principales: | Wang, Julie, Choy, Kay Weng, Lim, Hui Yin, Ho, Prahlad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472718/ https://www.ncbi.nlm.nih.gov/pubmed/36103084 http://dx.doi.org/10.1007/s11739-022-03081-y |
Ejemplares similares
-
Gut inflammation and tumorigenesis: every site has a different tale to tell
por: Vanoli, Alessandro, et al.
Publicado: (2023) -
Impact of 2020 SARS-CoV-2 outbreak on telemedicine management of cardiovascular disease in Italy
por: Molinari, Giuseppe, et al.
Publicado: (2020) -
Riechstörung als früher Marker für Covid-19
por: Oberhofer, Elke
Publicado: (2020) -
The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey
por: Tomaselli, Venera, et al.
Publicado: (2022) -
Intensive cardiac care unit admission trends during the COVID-19 outbreak in Italy: a multi-center study
por: Campanile, Alfonso, et al.
Publicado: (2021)